WEST PHARMACEUTICAL SERVICES INC
Ticker: 105770
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 844.90+5.0% | 804.60+5.0% | 766.50+9.8% | 698.00-6.5% | 746.90+6.4% | 702.10+1.0% | 695.40-7.0% | 747.40 |
| Total Income | 844.90+5.0% | 804.60+5.0% | 766.50+9.8% | 698.00-6.5% | 746.90+6.4% | 702.10+1.0% | 695.40-7.0% | 747.40 |
| EXPENSES | ||||||||
| Expenditure | 667.80+4.8% | 637.00+3.9% | 612.80+3.7% | 591.00+0.9% | 585.60+1.7% | 575.90+0.6% | 572.60+0.4% | 570.10 |
| Tax | 44.70+31.5% | 34.00+12.6% | 30.20+25.3% | 24.10-25.6% | 32.40+47.9% | 21.90+33.5% | 16.40-44.2% | 29.40 |
| PROFIT | ||||||||
| PBT | 180.10+4.8% | 171.90+9.5% | 157.00+42.1% | 110.50-32.8% | 164.50+27.8% | 128.70+1.0% | 127.40-31.9% | 187.00 |
| Net Profit | 138.80-0.9% | 140.00+6.2% | 131.80+46.8% | 89.80-34.0% | 136.00+22.2% | 111.30-3.5% | 115.30-28.5% | 161.30 |
| KEY METRICS | ||||||||
| OPM % | 20.96%+0.13pp | 20.83%+0.78pp | 20.05%+4.72pp | 15.33%-6.27pp | 21.60%+3.62pp | 17.98%+0.32pp | 17.66%-6.06pp | 23.72% |
| NPM % | 16.43%-0.97pp | 17.40%+0.20pp | 17.20%+4.33pp | 12.87%-5.34pp | 18.21%+2.36pp | 15.85%-0.73pp | 16.58%-5.00pp | 21.58% |
| EPS | 1.93-0.5% | 1.94+6.6% | 1.82+46.8% | 1.24-33.7% | 1.87+23.0% | 1.52-3.2% | 1.57-27.6% | 2.17 |
Corporate Events
Board MeetingWST
202631Aug
Board Meeting
CEO Transition — Michel Lagarde appointed as President and C…
SEC Filing ↗ Board MeetingWST
20264May
Board Meeting
Voting results from the 2026 Annual Meeting of Shareholders,…
SEC Filing ↗